BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4629310)

  • 1. Use of perphenazine in psychiatric emergencies: the concept of chemical restraint.
    Fann WE; Linton PH
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):478-82. PubMed ID: 4629310
    [No Abstract]   [Full Text] [Related]  

  • 2. Perphenazine-Associated Nausea: A Case of Protracted Withdrawal.
    Singh N; Sood N; Jolly T
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):606-608. PubMed ID: 34369907
    [No Abstract]   [Full Text] [Related]  

  • 3. [Technic and role of neuroleptic treatment with perphenazine in psychiatry].
    Ropert R
    Psychopharmacologie; 1971; ():71-82. PubMed ID: 5162009
    [No Abstract]   [Full Text] [Related]  

  • 4. [Perphenazine. Indications].
    Van Steenkiste J
    Psychopharmacologie; 1971; ():63-70. PubMed ID: 5162008
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study).
    McLaughlin BE
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995
    [No Abstract]   [Full Text] [Related]  

  • 6. Perphenazine serum levels in patients on standard doses.
    Haffner F
    Psychopharmacol Ser; 1989; 7():280-3. PubMed ID: 2687863
    [No Abstract]   [Full Text] [Related]  

  • 7. Low dose perphenazine and levodopa/carbidopa therapy in a patient with Parkinsonism and a psychotic illness.
    Hale MS; Bellizzi J
    J Nerv Ment Dis; 1980 May; 168(5):312-4. PubMed ID: 7365497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abscesses following prolonged intramuscular administration of perphenazine enantate.
    Starmark JE; Forsman A; Wahlström
    Acta Psychiatr Scand; 1980 Aug; 62(2):154-7. PubMed ID: 6110312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.
    Hanlon TE; Schoenrich C; Freinek W; Turek I; Kurland AA
    Psychopharmacologia; 1966; 9(4):328-39. PubMed ID: 4874349
    [No Abstract]   [Full Text] [Related]  

  • 10. The differential prediction of response to two anti-psychotic drugs.
    Goldstein BJ; Brauzer B; Clyde DJ; Caldwell JM
    Psychosomatics; 1969; 10(3):193-7. PubMed ID: 4897844
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma concentrations of perphenazine and its sulphoxide metabolite during continuous oral treatment.
    Hansen LB; Larsen NE
    Psychopharmacology (Berl); 1977 Jul; 53(2):127-30. PubMed ID: 408838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Perphenazine enantate in long-term therapy of psychoses].
    Gunby B
    Nord Psykiatr Tidsskr; 1968; 22(4):358-60. PubMed ID: 5710606
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with perphenazine enanthate].
    Rafter B
    Nord Psykiatr Tidsskr; 1971; 25(4):371-4. PubMed ID: 5154124
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of diazepam on human laboratory aggression: correlations with alcohol effects and hostility measures.
    Cherek DR; Steinberg JL; Kelly TH
    NIDA Res Monogr; 1987; 76():95-101. PubMed ID: 3125473
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of conventional neuroleptic therapy with depot neuroleptics. An attempt at economic evaluation.
    Lindholm H; Ljungberg L
    Acta Psychiatr Scand Suppl; 1973; 246():52-6. PubMed ID: 4520279
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined antidepressant-tranquilizer therapy of mixed psychiatric syndromes.
    Feldman PE
    Psychosomatics; 1965; 6(5):312-5. PubMed ID: 5319240
    [No Abstract]   [Full Text] [Related]  

  • 17. Haloperidol for acute psychiatric emergencies: a double-blind comparison with perphenazine in acute alcoholic psychosis.
    Ritter RM; Davidson DE
    South Med J; 1971 Feb; 64(2):249-50. PubMed ID: 4927220
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose-response relationships of perphenazine in the treatment of acute psychoses.
    Hansen LB; Larsen NE; Gulmann N
    Psychopharmacology (Berl); 1982; 78(2):112-5. PubMed ID: 6817364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of perphenazine and P-5227 in chronic schizophrenics: clinical and EEG effects.
    Holden JM; Itil TM; Keskiner A
    J Clin Pharmacol J New Drugs; 1969; 9(3):163-75. PubMed ID: 5255181
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral risperidone with lorazepam versus oral zuclopenthixol with lorazepam in the treatment of acute psychosis in emergency psychiatry: a prospective, comparative, open-label study.
    Hovens JE; Dries PJ; Melman CT; Wapenaar RJ; Loonen AJ
    J Psychopharmacol; 2005 Jan; 19(1):51-7. PubMed ID: 15671129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.